This Medical Moment – Season 2, Episode 1 – Brighter Outlook for Mental Health

When it comes to anxiety and depression, many struggle to find treatment plans that speak to their specific needs. Whether it be cost, time, or connection with the right providers, patients face obstacles that prevent them from finding a plan that works for them.

That’s why Brightside Health has created a proactive, evidence-backed, and personalized approach that is changing the standard of mental health care for all.

CEO Brad Kittredge sits down with PRECISIONeffect’s President Carolyn Morgan to share:

  • Where the current standard of mental health care falls short
  • How this digital, data-driven and personalized approach is empowering patients and generating impressive results
  • How technology can increase efficiency and find the right treatment faster
  • Advice for CEOs looking to break into the world of digital healthcare

Never Miss a Medical Moment

The most extraordinary moments in medicine are happening right now, but will these innovations get the opportunity to change lives?

Stay in the know and be the first to watch new episodes of This Medical Moment.


Advancements are happening in every corner of medicine. Brilliant new innovations are upending traditional thinking and power structures in the development of treatments and the delivery of care.

Join Carolyn Morgan in This Medical Moment and learn how others are overcoming the obstacles. She will be joined by guests who are leading critical changes in the standards of care.

What’s coming next? Find out. In a moment.

Beginning May 20, 2024, the Precision Value & Health family of brands is becoming Precision AQ.

Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life changing medicines. Our global offerings include:
  • Commercialization research, strategy and product planning
  • HEOR
  • Market access
  • Advertising, Branding & PR
  • Medical communications
  • Investor relations and external communications
  • Learning & development
  • Data and product solutions (Access Genius, Navigator365, OncoGenius, EHR Solutions, KOL/DOL Map)
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights. To find out more about our global services and our unified mission, to empower access to life-changing medicines for all, visit: Precision AQ

Accelerating clinical research and development through the combined power of trials, labs, and data science.

Demonstrating the value of life-science innovations with evidence and real-world expertise.